Cargando…

D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study

Endometrial hyperplasia is a threatening pathology driven by unopposed estrogen stimulus. Moreover, insulin may act on the endometrium, prompting further growth. We aimed at assessing whether D-chiro-Inositol, an insulin sensitizer with estrogen-lowering properties, might improve the condition of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porcaro, Giuseppina, Bilotta, Gabriele, Capoccia, Elena, Bezerra Espinola, Maria Salomé, Aragona, Cesare
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298331/ https://www.ncbi.nlm.nih.gov/pubmed/37373229 http://dx.doi.org/10.3390/ijms241210080

Ejemplares similares

Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
por: Nordio, Maurizio, et al.
Publicado: (2023)

d-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases
por: Espinola, Maria Salomé Bezerra, et al.
Publicado: (2021)

D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study
por: Monastra, Giovanni, et al.
Publicado: (2021)

Evaluating the Efficacy of Pervistop(®), a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study
por: Aragona, Cesare, et al.
Publicado: (2023)

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023)

CONCERN: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2012)

The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
por: Pintaudi, Basilio, et al.
Publicado: (2016)

D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2021)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

The effect of D-chiro-inositol on renal protection in diabetic mice
por: Fan, Chunxue, et al.
Publicado: (2022)

Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
por: Bizzarri, Mariano, et al.
Publicado: (2023)

Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk
por: Bezerra Espinola, Maria Salome, et al.
Publicado: (2021)

Effect of Oral High Molecular Weight Hyaluronic Acid (HMWHA), Alpha Lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D Supplementation in Pregnant Women: A Retrospective Observational Pilot Study
por: Parente, Eligio, et al.
Publicado: (2023)

New Insights into the Activities of D-Chiro-Inositol: A Narrative Review
por: Gambioli, Riccardo, et al.
Publicado: (2021)

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
por: Troisi, Jacopo, et al.
Publicado: (2019)

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence
por: Condorelli, Rosita A., et al.
Publicado: (2020)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
por: Benelli, Elena, et al.
Publicado: (2016)

Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
por: Unfer, Vittorio, et al.
Publicado: (2023)

D-Chiro-Inositol – Its Functional Role in Insulin Action and its Deficit in Insulin Resistance
por: Larner, Joseph
Publicado: (2002)

Determination of neo- and d-chiro-Inositol Hexakisphosphate in Soils by Solution (31)P NMR Spectroscopy
por: Turner, Benjamin L., et al.
Publicado: (2012)

Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data
por: Mancini, Mario, et al.
Publicado: (2016)

Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells
por: Filippello, Agnese, et al.
Publicado: (2020)

Effects of D-Chiro-Inositol on Glucose Metabolism in db/db Mice and the Associated Underlying Mechanisms
por: Fan, Chunxue, et al.
Publicado: (2020)

Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement
por: Cheng, Feier, et al.
Publicado: (2021)

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
por: Davinelli, Sergio, et al.
Publicado: (2020)

Determination of Urinary Myo-/Chiro-Inositol Ratios from Korean Diabetes Patients
por: Jung, Tae-Sik, et al.
Publicado: (2005)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

d-chiro-Inositol Ribophostin: A Highly Potent Agonist of d-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities
por: Mills, Stephen J., et al.
Publicado: (2020)

D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)
por: Monastra, Giovanni, et al.
Publicado: (2023)

Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus
por: Hong, Jun Hwa, et al.
Publicado: (2012)

High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries
por: Bevilacqua, Arturo, et al.
Publicado: (2021)

Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case–Control Analysis
por: Dellino, Miriam, et al.
Publicado: (2022)

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome
por: Pericuesta, Eva, et al.
Publicado: (2020)

Inositols: From Established Knowledge to Novel Approaches
por: Dinicola, Simona, et al.
Publicado: (2021)

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
por: Cheang, Kai I., et al.
Publicado: (2016)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2cdgrdmbo3s1nmlsm0a8u49kg5